Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817349 · ClinicalTrials.gov registry record
Angio-Seal Evolution Device Registry
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,004
- Enrollment target
NCT00817349: Completed study, sponsored by Abbott Medical Devices.
NCT00817349 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,004 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00817349 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,004 participants
- Enrollment target
Study Summary
Collect data on the use of the Angio-Seal Evolution Device in diagnostic and interventional patient populations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,004 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-04 |
What the finished NCT00817349 record still lists
NCT00817349 is an observational study that tracks outcomes without assigning an intervention. Its 1,004 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00817349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00817349 about?
NCT00817349 is a clinical study titled "Angio-Seal Evolution Device Registry". Collect data on the use of the Angio-Seal Evolution Device in diagnostic and interventional patient populations.
What is the current status of trial NCT00817349?
This trial is currently completed. The enrollment target is 1,004 participants. The study started on 2008-07. Estimated completion is 2010-04.
Who is sponsoring clinical trial NCT00817349?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia